George Perry

101.7k total citations · 18 hit papers
905 papers, 69.0k citations indexed

About

George Perry is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, George Perry has authored 905 papers receiving a total of 69.0k indexed citations (citations by other indexed papers that have themselves been cited), including 503 papers in Physiology, 381 papers in Molecular Biology and 131 papers in Pharmacology. Recurrent topics in George Perry's work include Alzheimer's disease research and treatments (468 papers), Cholinesterase and Neurodegenerative Diseases (123 papers) and Mitochondrial Function and Pathology (109 papers). George Perry is often cited by papers focused on Alzheimer's disease research and treatments (468 papers), Cholinesterase and Neurodegenerative Diseases (123 papers) and Mitochondrial Function and Pathology (109 papers). George Perry collaborates with scholars based in United States, Japan and Portugal. George Perry's co-authors include Mark A. Smith, Xiongwei Zhu, Akihiko Nunomura, Lawrence M. Sayre, Hyoung‐gon Lee, Rudy J. Castellani, Xinglong Wang, Paula I. Moreira, Peggy L.R. Harris and Sandra L. Siedlak and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

George Perry

888 papers receiving 67.4k citations

Hit Papers

Oxidative Damage Is the E... 1987 2026 2000 2013 2001 2001 1997 2021 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oxidative Damage Is the Earliest Event in Alzheimer Disease
    2001 1.5k citations Akihiko Nunomura, George Perry et al. profile →
  2. Mitochondrial Abnormalities in Alzheimer's Disease
    2001 1.1k citations Keisuke Hirai, Gjumrakch Aliev et al. profile →
  3. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
    1997 1.1k citations Mark A. Smith, George Perry et al. profile →
  4. The Amyloid-β Pathway in Alzheimer’s Disease
    2021 1.1k citations Harald Hampel, George Perry et al. profile →
  5. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
    2013 1.1k citations George Perry, Xiongwei Zhu et al. profile →
  6. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
    1997 1.0k citations George Perry et al. profile →
  7. Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
    2009 1.0k citations George Perry, Mark A. Smith et al. profile →
  8. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease
    1997 843 citations George Perry et al. profile →
  9. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
    2020 832 citations George Perry, Xiongwei Zhu et al. profile →
  10. Oxidative stress in Alzheimer’s disease
    2000 724 citations Mark A. Smith, Akihiko Nunomura et al. profile →
  11. Oxidative Stress and Neurotoxicity
    2007 690 citations George Perry, Mark A. Smith et al. profile →
  12. RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
    1999 614 citations George Perry, Keisuke Hirai et al. profile →
  13. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    1994 608 citations Mark A. Smith, George Perry et al. profile →
  14. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
    2009 585 citations Paula I. Moreira, Xiongwei Zhu et al. profile →
  15. Parkinson's Disease Is Associated with Oxidative Damage to Cytoplasmic DNA and RNA in Substantia Nigra Neurons
    1999 513 citations Jing Zhang, George Perry et al. American Journal Of Pathology profile →
  16. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
    1987 512 citations George Perry et al. profile →
  17. Chemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease
    2001 508 citations Mark A. Smith, George Perry et al. profile →
  18. Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
    2024 61 citations William Yang Wang, Xin Qi et al. Alzheimer s & Dementia profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
George Perry 36.7k 29.0k 10.4k 10.1k 9.3k 905 69.0k
Mark A. Smith 28.5k 0.8× 23.8k 0.8× 7.6k 0.7× 8.4k 0.8× 9.8k 1.1× 733 61.9k
Colin L. Masters 52.1k 1.4× 31.1k 1.1× 10.4k 1.0× 10.0k 1.0× 9.5k 1.0× 1.1k 82.7k
Rudolph E. Tanzi 32.5k 0.9× 22.9k 0.8× 7.6k 0.7× 7.0k 0.7× 9.1k 1.0× 483 57.5k
Mark P. Mattson 53.0k 1.4× 51.4k 1.8× 18.3k 1.8× 9.9k 1.0× 29.0k 3.1× 955 128.3k
David M. Holtzman 53.8k 1.5× 27.2k 0.9× 23.7k 2.3× 8.5k 0.8× 15.7k 1.7× 580 99.8k
William R. Markesbery 22.1k 0.6× 17.0k 0.6× 6.8k 0.7× 4.9k 0.5× 5.8k 0.6× 404 49.9k
John Hardy 49.9k 1.4× 34.8k 1.2× 18.0k 1.7× 11.8k 1.2× 20.6k 2.2× 884 93.4k
Bart De Strooper 28.1k 0.8× 26.7k 0.9× 6.3k 0.6× 7.6k 0.8× 9.2k 1.0× 392 51.6k
Dennis J. Selkoe 84.4k 2.3× 49.4k 1.7× 17.8k 1.7× 21.0k 2.1× 24.2k 2.6× 484 115.8k
Kaj Blennow 65.7k 1.8× 33.4k 1.2× 22.0k 2.1× 8.2k 0.8× 13.3k 1.4× 2.0k 122.7k

Countries citing papers authored by George Perry

Since Specialization
Citations

This map shows the geographic impact of George Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Perry more than expected).

Fields of papers citing papers by George Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Perry. The network helps show where George Perry may publish in the future.

Co-authorship network of co-authors of George Perry

This figure shows the co-authorship network connecting the top 25 collaborators of George Perry. A scholar is included among the top collaborators of George Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Perry. George Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, William Yang, Pamela B. Davis, Xin Qi, et al.. (2025). Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study. Journal of Alzheimer s Disease. 106(4). 1509–1522. 4 indexed citations
2.
Castellani, Rudolph J., Pouya Jamshidi, Germán Plascencia‐Villa, & George Perry. (2024). The Amyloid Cascade Hypothesis. American Journal Of Pathology. 195(11). 1988–1997. 7 indexed citations
3.
Everett, James, Jake Brooks, Frederik Lermyte, et al.. (2024). Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues. ACS Chemical Neuroscience. 15(7). 1469–1483. 5 indexed citations
4.
5.
Jimenez‐Vergara, Andrea C., Wendy Ortega-Lara, Cody O. Crosby, et al.. (2024). Fabrication and Characterization of Quad-Component Bioinspired Hydrogels to Model Elevated Fibrin Levels in Central Nervous Tissue Scaffolds. Gels. 10(3). 203–203. 1 indexed citations
6.
Plascencia‐Villa, Germán & George Perry. (2023). Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease. Antioxidants. 12(8). 1628–1628. 70 indexed citations
7.
Plascencia‐Villa, Germán & George Perry. (2023). Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases. International Journal of Molecular Sciences. 24(15). 12486–12486. 15 indexed citations
8.
Kepp, Kasper P., Stefano L. Sensi, Kasper Bendix Johnsen, et al.. (2023). The anti-amyloid monoclonal antibody Lecanemab: 16 cautionary notes. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations
9.
Plascencia‐Villa, Germán, Arati Tripathi, Xiongwei Zhu, et al.. (2023). Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation. ACS Chemical Neuroscience. 14(21). 3913–3927. 3 indexed citations
10.
Høilund‐Carlsen, Poul Flemming, Mona‐Elisabeth Revheim, Tommaso Costa, et al.. (2023). FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls. Diagnostics. 13(13). 2254–2254. 10 indexed citations
11.
Correia, Sónia C., Marco G. Alves, Pedro F. Oliveira, et al.. (2022). Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria. Antioxidants and Redox Signaling. 37(10-12). 739–757. 8 indexed citations
12.
Bajić, Vladan, et al.. (2021). Alzheimer’s and Consciousness: How Much Subjectivity Is Objective?. SHILAP Revista de lepidopterología. 16. 2288661773–2288661773. 1 indexed citations
13.
Everett, James, Frederik Lermyte, Jake Brooks, et al.. (2021). Biogenic metallic elements in the human brain?. Science Advances. 7(24). 67 indexed citations
14.
Hampel, Harald, Robert Nisticò, Nicholas T. Seyfried, et al.. (2021). Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence. Ageing Research Reviews. 69. 101346–101346. 97 indexed citations
15.
Zheng, Chunlei, Nathanael R. Fillmore, Jaime Ramos‐Cejudo, et al.. (2021). Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer s & Dementia. 18(6). 1248–1259. 20 indexed citations
16.
Mohammadi, Alireza, Peiman Brouki Milan, Farshid Sefat, et al.. (2018). Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders. Molecular Neurobiology. 56(1). 307–318. 9 indexed citations
17.
Everett, James, Joanna F. Collingwood, Jake Brooks, et al.. (2018). Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects. Nanoscale. 10(25). 11782–11796. 94 indexed citations
18.
Smith, Mark A., et al.. (2006). Compensatory responses induced by oxidative stress in Alzheimer disease. SHILAP Revista de lepidopterología. 4 indexed citations
19.
Perry, George, Akihiko Nunomura, Keisuke Hirai, et al.. (2000). Oxidative damage in Alzheimer's disease: the metabolic dimension. International Journal of Developmental Neuroscience. 18(4-5). 417–421. 96 indexed citations
20.
Nunomura, Akihiko, George Perry, Jing Zhang, et al.. (1999). RNA Oxidation in Alzheimer and Parkinson Diseases. 2(3). 227–230. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Smith Breakdown of academic impact, for papers by Colin L. Masters Breakdown of academic impact, for papers by Rudolph E. Tanzi Breakdown of academic impact, for papers by Mark P. Mattson Breakdown of academic impact, for papers by David M. Holtzman Breakdown of academic impact, for papers by William R. Markesbery Breakdown of academic impact, for papers by John Hardy Breakdown of academic impact, for papers by Bart De Strooper Breakdown of academic impact, for papers by Dennis J. Selkoe Breakdown of academic impact, for papers by Kaj Blennow
Rankless by CCL
2026